Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of Korean Breast Cancer Society
>
2001
>
4
Volume:
4
1. Immediate Free TRAM Flap Reconstruction after Mastectomy in Breast Cancer Patients.
Page:93—97
2. Combined Peritumoral and Subareolar Injection of Blue Dye Improves Sentinel Lymph Node Localization Rates.
Page:87—92
3. Clinical Significance of Rotter's Nodes in Patients with Breast Carcinomas.
Page:80—86
4. The Clinical Significance and Prognosis of Korean Young Age (younger or 35 year old) onset Breast Cancer.
Page:74—79
5. The Impact of Patient Age upon Locoregional and Systemic Failures after Breast Conservation Therapy: Comparison of the Results from the Groups above and below 35 Years.
Page:68—73
6. Breast Cancer in Third Decade-Does It Really Have a Poor Prognosis?.
Page:63—67
7. Paget's Disease of the Breast.
Page:57—62
8. Clinical Analysis of Stage I and II Breast Cancer.
Page:50—56
9. Clinical Analysis of Breast Cancer Surgeries in Korea.
Page:43—49
10. A Study on Modified Triple Test for Palpable Breast Mass.
Page:37—42
11. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer.
Page:161—166
12. Expression Pattern of Glucose Transporter GLUT1 Protein & Its Correlation with Prognostic Factors in Breast Cancer.
Page:161—166
13. The Expression of High Mobility Group I (Y) Proteins in Human Breast Cancer.
Page:1—5
14. Loss of Expression of the PTEN Gene Product in the Infiltrating Ductal Carcinoma of the Breast and Its Relationship with Clinicopathologic Factors.
Page:6—11
15. Significance on the Expression of Cyclin, MIB-1 in Benign and Malignant Papillary Lesion of the Breast.
Page:12—19
16. The Antiproliferating Effect of Diallyl Disulfide from Garlic on the Human Breast Cancer Cell Line (MCF-7).
Page:20—30
17. Use of the Triple Test for the Patients with Palpable Breast Masses.
Page:31—36
18. Prognosis of GLUT1 Expression in Human Breast Carcinoma.
Page:167—171
19. Relationship between Cathepsin D Expression and Other Prognostic Factors in Primary Breast Cancer.
Page:172—178
20. Apoptosis Related Protein Expressions in Immunohistochemical Staining Using Tissue Microarrays of Breast Cancer.
Page:179—184
21. The Significance of Cytokeratin-20 Detection in Peripheral Blood and Bone Marrow of Breast Cancer Patients.
Page:185—191
22. The Relationship between Plasminogen Acti- vator Inhibitor-1 and Bone Marrow Microme- tastases in Breast Cancer.
Page:192—197
23. A Pychosocial Support Program for Women with Primary Breast Carcinoma.
Page:99—105
24. A Pychosocial Support Program for Women with Primary Breast Carcinoma.
Page:99—105
25. Causes and Sexual Hormonal Changes in Patients with Gynecomastia.
Page:106—110
26. Causes and Sexual Hormonal Changes in Patients with Gynecomastia.
Page:106—110
27. Reduction Surgery for Giant Breast.
Page:111—114
28. Reduction Surgery for Giant Breast.
Page:111—114
29. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer.
Page:115—119
30. Incidence and Characteristics of Thyroid Nodules in Patients with Breast Cancer.
Page:115—119
31. Micrometastasis of Sentinel Lymph Node in Breast Cancer.
Page:120—127
32. Micrometastasis of Sentinel Lymph Node in Breast Cancer.
Page:120—127
33. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy.
Page:128—135
34. Factors Influencing the Recurrence of Breast Cancer Following Modified Radical Mastectomy.
Page:128—135
35. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer.
Page:136—143
36. Clinical Value of CEA, CA15-3 and TPS in Breast Cancer.
Page:136—143
37. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast.
Page:144—151
38. Expression of p53, c-erbB2, bcl-2, Cathepsin D in Infiltrating Ductal Cancer of the Breast.
Page:144—151
39. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer.
Page:152—160
40. Correlation between p53 and MIB1 Index Expression of Primary Tumor and Metastatic Lymph Node in Breast Cancer.
Page:152—160